Facial Aesthetics Market Scope
Facial aesthetics are non-surgical treatments that help in revitalizing the skin. Facial aesthetics are brisk and simple and far less expensive which is done through some devices or aesthetic implants. It’s a decent initial step for women as well as men to accept and implement a wider range of medical aesthetic services. It has additionally pulled in a huge following from patients who might never have thought about healing surgery yet are very satisfied with snappy and short-term care. Dermal fillers and botulinum toxin are used to restore the skin’s naturally youthful appearance. Non-surgical cosmetic interventions can be performed by anyone, and anyone can set up training courses. There are no guidelines regarding what constitutes adequate training or verification of courses at present.
The Facial Aesthetics market study is segmented by Type (Dermal Fillers, Botulinum Toxin, Chemical Peel and Microdermabrasion), by Application (Facial Line Correction Treatment, Scar Treatment, Lip Treatments, Restoration of Volume/ Fullness and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Facial Aesthetics market throughout the predicted period.
Allergan (Ireland), Solta Medical International Inc. (United States), Syneron Medical (United States), Photomedex, Inc. (United States), Cynosure (United States), Lumenis Ltd. (Israel), Johnson & Johnson (United States), Zeltiq Aesthetics (United States), Merz Pharmaceuticals GmbH (Germany), Galderma (Switzerland), Alma Lasers Ltd. (Israel), Bausch Health Companies Inc. (Canada), Merz Pharmaceuticals GmbH (Germany), Novartis AG (Switzerland) and Nestlé Skin Health (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Anika Therapeutics Inc. (United States), Teoxane SA (Switzerland), Alpha Aesthetics (United States) and Galderma Laboratories, L.P. (United States).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Facial Aesthetics market by Type, Application and Region.
On the basis of geography, the market of Facial Aesthetics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In January 2020, Allergan announced the launch of the SkinMedica Instant Bright Eye Cream for enhancing the skin around eyes, On January 10th 2020 - Revance Therapeutics, a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, signed a U.S. distribution agreement with TEOXANE SA , making Revance the exclusive commercialization partner of the Swiss company’s modern and innovative Resilient Hyaluronic Acid (RHA) technology. and In April 2019, Merz Pharma launched a new dermal filler called the Belotero Revive dermal filler, a combination of hyaluronic acid and glycerol
Currently, there is no regulatory body or any formal process of regulation regarding the administration of non-surgical facial aesthetics. Regardless of the societal expectation that such an industry would have strict regulations and guidelines, currently, only procedures requiring surgery (i.e. those involving a surgical incision) are required to be carried out by a qualified medical professional. Botulinum toxin injections, dermal fillers, and other ‘minimally invasive’ cosmetic treatments can be administered by anyone, regardless of their qualifications.
- Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures
- Increasing Demand for Aesthetic Treatments among Men
- Increasing Number of Clinics and Medical Spas
- High Availability of Financial and Infrastructural Resources with Hospitals
- The Availability of Technologically Advanced & User-Friendly Products
- Technologically Advanced Devices
- High Cost of Treatment
- Risk of Malfunctions Associated Mostly With Implants
Key Target Audience
Service Providers of Facial Aesthetics, End-Users, Manufacturers of Aesthetics Devices and Cosmetic, Healthcare Industry, Governmental Bodies, Regulatory Bodies and Others
Frequently asked questions:1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.2. How big is the Facial Aesthetics Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.